Standout Papers

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cance... 2023 2026 202483
  1. Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer (2023)
    Laura A. Huppert, Özge Gümüşay et al. CA A Cancer Journal for Clinicians

Immediate Impact

19 standout
Sub-graph 1 of 7

Citing Papers

Alternative splicing and related RNA binding proteins in human health and disease
2024 Standout
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
2 intermediate papers

Works of Damé Idossa being referenced

Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer
2023 Standout
Targeted next‐generation sequencing in myelodysplastic syndromes and prognostic interaction between mutations and IPSS‐R
2017

Author Peers

Author Last Decade Papers Cites
Damé Idossa 95 68 2 71 20 229
Fabrice Jardin 80 58 46 21 271
Yuliya Linhares 91 66 92 27 273
Nazanin Aghel 94 49 78 17 265
Jacqueline Wang 115 45 41 20 254
A Pedrazzini 135 68 66 23 243
Michelle Purdom 129 74 30 13 289
Danko Martincic 65 53 113 17 217
Katjana Schwab 133 53 37 22 268
Manfred Ahlgrimm 87 28 49 17 263
Fernando Solano 62 28 53 16 259

All Works

Loading papers...

Rankless by CCL
2026